Conglomerates of tenatoprazole potassium salts

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8546574
APP PUB NO 20110060002A1
SERIAL NO

12448055

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to conglomerates of tenatoprazole potassium salts of the following general formula (I), that consist of an equimolar mixture of enantiomers having R and S configurations and capable of crystallization in the form of a conglomerate, wherein said salts are selected from tenatoprazole dehydrated potassium salt, tenatoprazole potassium dimethanolate, tenatoprazole potassium diethanolate and tenatoprazole potassium ethylene-glycolate. The invention also relates to a pharmaceutical composition containing such salt, and to the use of said salt.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SIDEM PHARMA SA2613 LUXEMBOURG

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bernad, Stéphane La Varenne Saint-Hilaire, FR 1 0
Charbit, Suzy Creteil, FR 19 50
Cohen, Avraham Tel-Aviv, IL 26 206
Coquerel, Gérard Boos, FR 16 12
Petit, Marie-Noëlle Mont Saint-Aignan, FR 2 1
Schutze, François Saint-Nom-la-Breteche, FR 2 0
Tauvel, Guillaume Rouen, FR 3 6

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 1, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00